Priya Rastogi
Pittsburgh medical oncologist who serves as CEO and Medical Director of the NSABP Foundation, leading its breast cancer trial portfolio.
Overview
Priya Rastogi is Chief Executive Officer and Medical Director of the NSABP Foundation and Associate Professor of Medicine at the University of Pittsburgh. A breast medical oncologist, she was first author of the long-term update of the NSABP B-18 and B-27 neoadjuvant chemotherapy trials. She oversees the foundation's clinical trial operations and its participation in the NRG Oncology cooperative group.
| Title | Journal | Year |
|---|---|---|
| Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27 | Journal of Clinical Oncology | 2008 |
Pages like this
not linked directly; found by shared links- PersonNorman Wolmark
Shares NSABP Foundation, HER2-positive breast cancer, HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer, clinical trials.
- PersonMichael Gnant
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer, clinical trials.
- PersonSunil Lakhani
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
- PersonIsabel T. Rubio
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
- PersonSuzette Delaloge
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
- PersonEva Ciruelos
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
- PersonDorraya El-Ashry
Shares Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
- PersonDonna McKay
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, breast cancer.